With the growing acceptance of medical marijuana in the United States, where an estimated 85% of citizens support its legalization for medicinal use, researchers are diligently examining its efficacy in treating various conditions. In particular, there is a burgeoning interest in the role of cannabis and its non-psychoactive component, CBD (cannabidiol), in managing symptoms of Parkinson’s disease. However, the therapeutic use of cannabis remains a subject surrounded by both hopeful anecdotes and scientific scrutiny.
